Small Pharmaceuticals
Market Cap
₹21,520 Cr.
P/E
29.79
  • Pfizer
  • Astrazeneca Pharma
  • Eris Lifesciences
  • TJI Pharma

FAQs on Pfizer Ltd. Shareprice

Pfizer has given better returns compared to its competitors.
Pfizer has grown at ~11.23% over the last 9yrs while peers have grown at a median rate of 8.63%

Pfizer is not expensive.
Latest PE of Pfizer is 30.02, while 3 year average PE is 33.37.
Also latest EV/EBITDA of Pfizer is 20.55 while 3yr average is 25.03.

Growth Table

  • Pfizer Ltd.
  • Astrazeneca Pharma
  • Eris Lifesciences

Balance Sheet

  • Pfizer Ltd.
  • Astrazeneca Pharma
  • Eris Lifesciences

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Pfizer Ltd.
  • Astrazeneca Pharma
  • Eris Lifesciences

Cash Flow

  • Pfizer Ltd.
  • Astrazeneca Pharma
  • Eris Lifesciences

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Pfizer Ltd.
  • Astrazeneca Pharma
  • Eris Lifesciences

Quarterly Results

  • Pfizer Ltd.
  • Astrazeneca Pharma
  • Eris Lifesciences

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Pfizer Ltd. Financials

Balance sheet of Pfizer is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Pfizer is decreasing.
Latest net debt of Pfizer is -₹6,215.3 Crs as of Mar-26.
This is less than Mar-25 when it was -₹5,597.54 Crs.

The profit is oscillating.
The profit of Pfizer is ₹722 Crs for Mar 2026, ₹768 Crs for Mar 2025 and ₹551 Crs for Mar 2024

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Pfizer latest dividend payout ratio is 47.5% and 3yr average dividend payout ratio is 58.29%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Capital Work in Progress

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech